“…The industry also employees 90,000 sales representatives and spends $15 billion annually on selling activities. Representatives use all-expense-paid trips, cash payments, and other incentives to persuade physicians to prescribe particular drugs to their patients.
Big Pharma's abuses have been widely documented. However, when it comes to eliminating unfair practices, little action has been taken. Likely reasons include not only the influence of lobbyists, but also revolving-door politics, free-market ideologies, and regulators' financial dependence on the pharmaceutical industry. Even the FDA has been accused of being too lax in its regulation practices. It's no wonder: the pharmaceutical industry pays the FDA hefty fees to expedite the drug approval process….”
True or not? Has the FDA been influenced regarding Actipatch by the powers that be and lobbying, or not? With the many countries that have cleared including the NHS covering costs, it's time for BIEL in the USA I would think, but we wait. Have the expediting winds kicked-in?
News 
Market Data 
Discover 
AI
